Evaluation of Succinate Metoprolol on Heart Rate in the Stable Angina Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 251 participants.

Also called NCT01213173

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 251 participants (enrolled count) (from the registry)
Sponsor
  • AstraZeneca Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01213173
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01213173. Randomized; no masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2011-09 (actual). Results posted on 2013-08-26.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Succinate Metoprolol on Heart Rate in the Stable Angina Patients
Condition
Angina Pectoris
Intervention (Drug)
Succinate Metoprolol (Betaloc ZOK®)
Intervention (Drug)
Succinate Metoprolol (Betaloc ZOK®)
Lead sponsor
AstraZeneca (class: industry)

Record details

Record id
cardio:ct-nct01213173
Content hash
56bbfc275d2ef7a570c582ce29f43fca3951b29fd1dfb6e8eb4baabe6bbeb655